Do you have pancreatic cancer that is "locally advanced"? This means it can't be removed by surgery, but it hasn't spread elsewhere. Have you recently had chemotherapy, and your tumor has either shrunk or stopped growing? If so, you might be able to join a research study. The study looks at whether adding a high dose of radiation therapy can help people live longer or feel better compared to the usual treatment.

Have you been diagnosed with relapsed or refractory multiple myeloma? If so, you may be able to take part in a research study looking at the safety and tolerability of giving a new drug called ABBV-453 alone and in combination with other antimyeloma drugs to patients with relapsed or refractory multiple myeloma.

Do you have asthma? Would you like to learn about a new medicine that might help? We are looking for people aged 18-65 with asthma to join our study. You will be paid for your time. Compensation is provided.

The purpose of this study is to gather insight directly from people with eating disorders or who have cared for someone with an eating disorder about the ways the eating disorder has impacted areas of their life including education, work, social relationships, and participation in recreational or community activities.

Do you or your child have hidradenitis suppurativa? Would you be interested in hearing more about a clinical study on hidradenitis suppurativa? If so, you may be able to participate in a research study to find out how effective and safe the study medication Ruxolitinib is in patients with hidradenitis suppurativa.

The purpose of this study is to evaluate the distribution of a human leukocyte antigen genotype in adults who were recently diagnosed with type 1 diabetes

The goal of this Study is to provide prospective evidence of the frequency of skin discoloration in patients who have received the Magtrace® tracer for sentinel lymph node biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur, by using patient reported outcome measures such as questionnaires.

This research study aims to investigate the use of circulating tumor DNA (ctDNA) monitoring to detect early signs of cancer recurrence in patients with triple-negative breast cancer (TNBC) after standard treatment. TNBC is aggressive and has a higher risk of recurrence, often detected only after symptoms appear. This study will monitor ctDNA levels through blood samples collected during and after adjuvant therapy. If ctDNA is not detected, participants will continue monitoring. If ctDNA is detected, the study offers an investigational treatment, datopotamab deruxtecan (Dato-DXd), to address this potential recurrence risk. Participation in this study will help determine if ctDNA monitoring can improve the early detection of recurrence and potentially lead to better treatment strategies and outcomes for patients with TNBC in the future.

Do you have protein in your urine and have had a kidney biopsy? You may be able to participate in a research study to test to see if a study drug can reduce the amount of protein in your urine.

The purpose of this study is to learn how microbes in the uterus and gut (bacteria, viruses, fungi) and your own innate immune system (the first line of defense of the body) impacts how well certain treatments work for endometrial cancer. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.